ONCOGENE

May 2012 Volume 31 Number 22, pp 2703 - 2804
---------------------------------------------------------------------
4th Molecular Diagnostics for Cancer Drug Development
25-28 June, Boston

Profiling the cutting-edge of personalized medicine in oncology to
give you a thorough review of end to end drug and diagnostic development
from discovery to commercialization, including regulatory environment,
pharma/biotech strategies and emerging technologies.
http://links.ealert.nature.com/ctt?kn=53&ms=MzkyODM2MDgS1&r=Mzg0ODUxNzc0MwS2&b=2&j=MTQ0ODQ2NzgzS0&mt=1&rt=0

http://moleculardiagnostics-cancer.com/